Premium
The Structural Plasticity of the C Terminus of p21 Cip1 is a Determinant for Target Protein Recognition
Author(s) -
Esteve Vicent,
Canela Núria,
RodriguezVilarrupla Aina,
Aligué Rosa,
Agell Neus,
Mingarro Ismael,
Bachs Oriol,
PérezPayá Enrique
Publication year - 2003
Publication title -
chembiochem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.05
H-Index - 126
eISSN - 1439-7633
pISSN - 1439-4227
DOI - 10.1002/cbic.200300649
Subject(s) - proliferating cell nuclear antigen , microbiology and biotechnology , domain (mathematical analysis) , c terminus , biology , nuclear protein , cell cycle , protein structure , plasma protein binding , peptide , protein domain , peptide sequence , biochemistry , biophysics , cell growth , cell , amino acid , gene , transcription factor , mathematical analysis , mathematics
The cyclin‐dependent kinase inhibitory protein p21 Cip1 might play multiple roles in cell‐cycle regulation through interaction of its C‐terminal domain with a defined set of cellular proteins such as proliferating cell nuclear antigen (PCNA), calmodulin (CaM), and the oncoprotein SET. p21 Cip1 could be described as an intrinsically unstructured protein in solution although the C‐terminal domain adopts a well‐defined extended conformation when bound to PCNA. However, the molecular mechanism of the interaction with CaM and the oncoprotein SET is not well understood, partly because of the lack of structural information. In this work, a peptide derived from the C‐terminal domain of p21 Cip1 that covers the binding domain of the three above‐mentioned proteins was used to demonstrate that the C‐terminal domain of p21 recognizes multiple ligands through its ability to adopt multiple conformations. The conformation is dictated by tertiary contacts rather than by the primary sequence of the protein. Our results suggest that the C‐terminal domain of p21 Cip1 adopts an extended structure when bound to PCNA and probably when bound to the oncoprotein SET, but an α helix when bound to CaM.